Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/19/2003CN1404471A Substituted piperazine compounds
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404467A Aminosulfonylbiphenyl derivatives
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404396A Polypeptoid pulmonary surfactants
03/19/2003CN1404395A Antiadhesive carbohydrates
03/19/2003CN1404394A Pharmaceutical compositions containing steroidal structures and uses thereof
03/19/2003CN1404393A Use of a compound for preparing a drug
03/19/2003CN1404392A Antiviral azaindole derivatives
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1404390A TNF-alpha inhibitors
03/19/2003CN1404389A Timed pulsatile drug delivery systems
03/19/2003CN1404388A Multi-step drug dosage forms
03/19/2003CN1404382A Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
03/19/2003CN1403574A Modified EB virus LMP1 coding sequence and its prepn and application
03/19/2003CN1403470A Astragalus saponin A with the function of resisting myocardial fibrillation
03/19/2003CN1403469A Antineoplastic compound and its prepn and medicinal use
03/19/2003CN1403468A Prepn of epimedium general flavone with osteoporosis resisting function
03/19/2003CN1403466A Syringic general saponin extractive and its prepn and medicinal composition
03/19/2003CN1403455A Synthesis of 2-oxazolidone derivate by one still process
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403453A Quinoline and quinazoline compound for treating benign prostatic hyperplasia specially
03/19/2003CN1403452A Astragalus calycosin and its glycoside with the function of resisting myocardial ischemia
03/19/2003CN1403451A Balsamiferous biumea general flavone extractive and its extraction process and medicinal application
03/19/2003CN1403450A Prepn process and medicine composition of andrographolide derivatives
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403439A Phytosphingosine derivate with antitumor activity
03/19/2003CN1403172A Medicine release controller for treating women's climacteric syndrome
03/19/2003CN1403168A Medical composite biological bone cement powder, bone cement liquid and composite biological bore cement
03/19/2003CN1403157A Method for treating female sexual dysfunction and evaluating compound for treating female sexual dysfunction
03/19/2003CN1403142A Suppository for treating piles and other anorectal diseases and its prepn
03/19/2003CN1403128A Chinese medicine for treating deep ulcer and bedsore
03/19/2003CN1403124A Cape jasmine medicine for dredging meridian and reducing blood fat and its prepn
03/19/2003CN1403113A Medicine for invigorating kidney, promoting blood circulation and promoting skeleton formation and its prepn
03/19/2003CN1403091A Prepn of ulcer-resisting chitosan zinc compound
03/19/2003CN1403090A Solid puerarin-phosphatide dispersion and its prepn
03/19/2003CN1403089A Chinese medicine prepn containing arasaponin and its prepn process
03/19/2003CN1403088A Medicine composition containing polydatin or its salt and its use in preparing medicine
03/19/2003CN1403087A Slow-releasing Benproperine phosphate dripping pill and its prepn process
03/19/2003CN1403086A Coculine-phosphatide composite and its prepn
03/19/2003CN1403085A Medicine for inhibiting and killing body's superficial pathogenic fungi
03/19/2003CN1403084A Ganciclovir injection and its production process
03/19/2003CN1403083A Fast disintegrated and stripped oral cilostazol table and its prepn process
03/19/2003CN1403082A Orally disintegrating Nifedipine prepn and its recipe
03/19/2003CN1403081A Application of tadins inhibiting formation of osteoclast
03/19/2003CN1403080A Application of kaempferol and its derivative in preparing medicine for cardiac and cerebral vascular diseases
03/19/2003CN1403079A Application of chuanliansu as specific P-type calcium passage blocker
03/19/2003CN1403078A Slow-releasing prepn containing p-acetamidophenol and opium
03/19/2003CN1403077A Slow-release preparation
03/19/2003CN1403076A Multi-particle improved release composition
03/19/2003CN1402981A Disinfectant lotion for body's vulva and vagina
03/19/2003CN1103338C Heterocyclic compound for treating myocardial ischaemia
03/19/2003CN1103335C Processfor producing 2,5-disubstituted pyridines
03/19/2003CN1103333C Selective thrombin inhibitors
03/19/2003CN1103232C Anticancer compound agent
03/19/2003CN1103226C Medicine for treating burn and scald
03/19/2003CN1103225C Plaster for treating osteophytosis
03/19/2003CN1103221C Medicine for treating HIV infections
03/19/2003CN1103220C Medicinal composition for treating optic atrophy
03/19/2003CN1103219C Formulations containing hyaluronic acid
03/19/2003CN1103218C Ointment preparation for treating dermatosis and its preparing method
03/19/2003CN1103217C Aqueous eye drops containing apafant as active ingredient
03/19/2003CN1103216C Pharmaceutical emulsions containing bioactive steroids
03/19/2003CA2422817A1 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
03/19/2003CA2422816A1 Disinfectant agent
03/18/2003WO2002024712A1 Triazolo-epothilones
03/18/2003WO2002024637A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534685 Liquid mixture having cetane number higher than 40 comprising typical diesel gas oil cut having specified boiling point and density range, and specified concentration of one or more dialkyl-polyformal compounds
03/18/2003US6534676 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
03/18/2003US6534663 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids
03/18/2003US6534660 CC-1065 analog synthesis
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534639 Guanidinium functionalized oligonucleotides and method/synthesis
03/18/2003US6534635 Tissue inhibitors of metalloproteinase (TIMP); electron-accepting group causes it to lose its ability to bind to metalloproteinase; carbamylation; inhibition of metastasis of cancer or vascularization
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534574 Bicyclo(2.2.1)heptane dicarboxylate salts; clarifying polyolefins; shelf life, storage stability
03/18/2003US6534548 Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
03/18/2003US6534547 Filtration, sterilization, biological injection of mixture of benzyl alcohol, water, phospholipid-free emulsifier, tonicity agent and propofol
03/18/2003US6534546 Aniline derivatives possessing an inhibitory effect of nitric oxide synthase
03/18/2003US6534545 Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534543 Oxa acids and related compounds for treating skin conditions
03/18/2003US6534541 Treatment of ocular disorders
03/18/2003US6534540 Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor
03/18/2003US6534539 Pharmaceutical composition and method for treatment of dyspepsia
03/18/2003US6534538 A non-murine heart valve cell containing an exogenous nucleic acid that encodes a polypeptide having nitric oxide synthase activity; slows heart valve degeneration, thrombosis, and calcification, treats carcinoid heart disease
03/18/2003US6534537 Benign prostatic hyperplasia
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/18/2003US6534531 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
03/18/2003US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors
03/18/2003US6534528 Treatment of a leg ulcer or a decubitus ulcer, wherein the ulcer is not infected, which comprises contacting the ulcer with a pharmaceutical which comprises a powder and at least one 1-hydroxy-2-pyridone
03/18/2003US6534527 Edible herbal compositions for relieving nicotine craving
03/18/2003US6534526 Administering adrenergic antagonist; domperidone
03/18/2003US6534525 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
1 ... 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 5546 5547 5548 5549 5550 5551 5552 ... 7860